Accordingly, overexpression of PDK4 partially blocked transforming growth factor (TGF) β-induced EMT and, vice versa, PDK4 inhibition was sufficient to induce EMT and drug (erlotinib) resistance in lung cancer cells. The gene discussed is PDK4; the disease is lung carcinoma.